Lapointe-Shaw L - Search Results

1

Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time.

Lapointe-Shaw L, Chung H, Holder L, Kwong JC, Sander B, Austin PC, Janssen HLA, Feld JJ. Lapointe-Shaw L, et al. Hepatology. 2021 Jun;73(6):2141-2154. doi: 10.1002/hep.31557. Epub 2021 Jun 15. Hepatology. 2021. PMID: 32931613

2

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes.

Cheung AC, Lapointe-Shaw L, Kowgier M, Meza-Cardona J, Hirschfield GM, Janssen HL, Feld JJ. Cheung AC, et al. Aliment Pharmacol Ther. 2016 Jan;43(2):283-93. doi: 10.1111/apt.13465. Epub 2015 Nov 12. Aliment Pharmacol Ther. 2016. PMID: 26559762

3

Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.

Lapointe-Shaw L, Voruganti T, Kohler P, Thein HH, Sander B, McGeer A. Lapointe-Shaw L, et al. Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):1047-1055. doi: 10.1007/s10096-016-2890-7. Epub 2017 Jan 11. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28078557

4

Effectiveness of a financial incentive to physicians for timely follow-up after hospital discharge: a population-based time series analysis.

Lapointe-Shaw L, Mamdani M, Luo J, Austin PC, Ivers NM, Redelmeier DA, Bell CM. Lapointe-Shaw L, et al. CMAJ. 2017 Oct 2;189(39):E1224-E1229. doi: 10.1503/cmaj.170092. CMAJ. 2017. PMID: 28970260 Free PMC article.

5

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.

Lapointe-Shaw L, Georgie F, Carlone D, Cerocchi O, Chung H, Dewit Y, Feld JJ, Holder L, Kwong JC, Sander B, Flemming JA. Lapointe-Shaw L, et al. PLoS One. 2018 Aug 22;13(8):e0201120. doi: 10.1371/journal.pone.0201120. eCollection 2018. PLoS One. 2018. PMID: 30133446 Free PMC article.

6

Mediation analysis with a time-to-event outcome: a review of use and reporting in healthcare research.

Lapointe-Shaw L, Bouck Z, Howell NA, Lange T, Orchanian-Cheff A, Austin PC, Ivers NM, Redelmeier DA, Bell CM. Lapointe-Shaw L, et al. BMC Med Res Methodol. 2018 Oct 29;18(1):118. doi: 10.1186/s12874-018-0578-7. BMC Med Res Methodol. 2018. PMID: 30373524 Free PMC article.

7

Death and readmissions after hospital discharge during the December holiday period: cohort study.

Lapointe-Shaw L, Austin PC, Ivers NM, Luo J, Redelmeier DA, Bell CM. Lapointe-Shaw L, et al. BMJ. 2018 Dec 10;363:k4481. doi: 10.1136/bmj.k4481. BMJ. 2018. PMID: 30530782 Free PMC article.

8

Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study.

Lapointe-Shaw L, Bell CM, Austin PC, Abrahamyan L, Ivers NM, Li P, Pechlivanoglou P, Redelmeier DA, Dolovich L. Lapointe-Shaw L, et al. BMJ Qual Saf. 2020 Jan;29(1):41-51. doi: 10.1136/bmjqs-2019-009545. Epub 2019 Aug 8. BMJ Qual Saf. 2020. PMID: 31395749

9

Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis.

Lapointe-Shaw L, Austin PC, Chung H, Sander B, Kwong JC, Feld JJ. Lapointe-Shaw L, et al. J Hepatol. 2019 Dec;71(6):1251-1254. doi: 10.1016/j.jhep.2019.06.015. Epub 2019 Oct 22. J Hepatol. 2019. PMID: 31648817 No abstract available.

10

Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time.

Lapointe-Shaw L, Chung H, Sander B, Kwong JC, Holder L, Cerocchi O, Austin PC, Feld JJ. Lapointe-Shaw L, et al. Liver Int. 2021 Jan;41(1):33-47. doi: 10.1111/liv.14670. Liver Int. 2021. PMID: 32956567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters